Understanding the ROI Potential of your Workplace Substance Abuse Screening Program
Thank you for attending DISA's 2026 Screening, Safety, & Strategy Conference! The presentation and full audio recording are below.
Note: Click play on the video player, and then switch to the slides at the bottom right of the player window to follow along.
Use the arrow keys on your keyboard to navigate through the presentation.
Understanding the ROI Potential of your Workplace Substance Abuse Screening Program
The majority of employers consider their workplace drug screening programs to be a critical tool for maintaining safety and compliance, and they are 100% correct. What is not as well understood is how your workplace drug screening program can MAKE YOU MONEY! More than half of the states offer some form of financial incentive for employers that voluntarily comply with specific rules or participate in Drug-Free Workplace Programs (DFWP), ranging from insurance premium discounts for simply having a screening program in place to denying costly Workers’ Compensation or unemployment claims solely based on a positive substance test. These opportunities must be understood and leveraged. In addition to direct incentives, this session also addresses the “invisible” cost drivers that shape ROI—fewer accidents and injuries, reduced downtime, lower abuse-related loss, and improved productivity. The savings from these financial incentives often cover the costs of your entire screening program and more!
Key Learnings:
- Overview of the opportunities employers should consider to leverage financial incentives.
- Deep dive into the program requirements by state.
- Policy and procedural considerations, including how to estimate indirect savings from reduced accidents, downtime, abuse-related loss, and productivity drag.